SCHEMBL17060461

SCHEMBL17060461

COc1ncc(-c2ccc3nccc(-c4ccc(C)cc4)c3c2)cc1NS(=O)(=O)c1cc(F)cc(F)c1

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 18/20 0.78
MTOR P42345 4/20 0.68
PIK3CD O00329 3/20 0.63
PIK3CB P42338 3/20 0.63
PIK3CG P48736 3/20 0.63
PIK3R1 P27986 1/20 0.63
PRKDC P78527 1/20 0.63
PDE4D Q08499 1/20 0.63
RICTOR Q6R327 1/20 0.63
RPTOR Q8N122 1/20 0.63
PIK3C3 Q8NEB9 1/20 0.63
PIP4K2C Q8TBX8 1/20 0.63
MAPKAP1 Q9BPZ7 1/20 0.63
MLST8 Q9BVC4 1/20 0.63
IRAK3 Q9Y616 1/20 0.63
HDAC1 Q13547 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15599518 0.88 PIK3CA (0.74) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL17060446 0.88 PIK3CA (1.00) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL25495122 0.83 PIK3CA (0.83) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL731865 0.82 PIK3CA (0.72) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL17060432 0.81 PIK3CA (1.00) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL741445 0.81 PIK3CA (1.00) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL1300383 0.80 PIK3CA (0.86) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL627675 0.79 PIK3CA (0.77) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL25494702 0.79 PIK3CA (0.66) PIK3CAMTORPIK3CDPIK3CBPIK3CG
SCHEMBL25495105 0.79 PIK3CA (0.84) PIK3CAMTORPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2915810-A1 N-(5-(QUINOLIN-6-YL)PYRIDIN-3-YL) BENZSULFAMIDE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE THEREOF The Second Military Medical University, PLA (CN) 2015-09-09 EP disclosed